重编程
MEF2C公司
转录因子
染色质
细胞生物学
关贸总协定
组蛋白
表观遗传学
瑞士/瑞士法郎
增强子
生物
染色质重塑
肌钙蛋白
遗传学
基因
血清反应因子
作者
Glynnis A. Garry,Svetlana Bezprozvannaya,Kenian Chen,Huanyu Zhou,Hisayuki Hashimoto,María Gabriela Morales,Ning Liu,Rhonda Bassel‐Duby,Eric N. Olson
标识
DOI:10.1038/s41556-021-00668-z
摘要
Direct cardiac reprogramming of fibroblasts to cardiomyocytes presents an attractive therapeutic strategy to restore cardiac function following injury. Cardiac reprogramming was initially achieved through overexpression of the transcription factors Gata4, Mef2c and Tbx5; later, Hand2 and Akt1 were found to further enhance this process1-5. Yet, staunch epigenetic barriers severely limit the ability of these cocktails to reprogramme adult fibroblasts6,7. We undertook a screen of mammalian gene regulatory factors to discover novel regulators of cardiac reprogramming in adult fibroblasts and identified the histone reader PHF7 as the most potent activating factor8. Mechanistically, PHF7 localizes to cardiac super enhancers in fibroblasts, and through cooperation with the SWI/SNF complex, it increases chromatin accessibility and transcription factor binding at these sites. Furthermore, PHF7 recruits cardiac transcription factors to activate a positive transcriptional autoregulatory circuit in reprogramming. Importantly, PHF7 achieves efficient reprogramming in the absence of Gata4. Here, we highlight the underexplored necessity of cardiac epigenetic readers, such as PHF7, in harnessing chromatin remodelling and transcriptional complexes to overcome critical barriers to direct cardiac reprogramming.
科研通智能强力驱动
Strongly Powered by AbleSci AI